Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayaganesh V Natarajan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 28, 2014
Sustained-release from nanocarriers: a reviewJayaganesh V Natarajan, Chandra Nugraha, Xu Wen Ng, et al.
Frontiers in Bioscience (Scholar Edition)|June 3, 2010
Polymer- and liposome-based nanoparticles in targeted drug deliverySubbu S Venkatraman, Lwin Lwin Ma, Jayaganesh V Natarajan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 23, 2003
Controlled targeting of liposomal doxorubicin via the folate receptor in vitroJustin M Saul, Ananth Annapragada, Jayaganesh V Natarajan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 4, 2005
Folate targeting of drug carriers: a mathematical modelKetan B Ghaghada, Justin Saul, Jayaganesh V Natarajan, et al.
International Journal of Nanomedicine|January 26, 2012
Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eyeJayaganesh V Natarajan, Marcus Ang, Anastasia Darwitan, et al.
Expert Opinion on Drug Delivery|May 13, 2016
Drug, delivery and devices for diabetic retinopathy (3Ds in DR)Jayabalan Nirmal, Krishna Radhakrishnan, Miguel Moreno, et al.
Drug Delivery and Translational Research|March 20, 2015
Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedropsTina T Wong, Gary D Novack, Jayaganesh V Natarajan, et al.
Plos One|September 21, 2011
Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eyeJayaganesh V Natarajan, Sujay Chattopadhyay, Marcus Ang, et al.
Scientific Reports|December 3, 2017
Characterization of liposomal carriers for the trans-scleral transport of RanibizumabRini Rachel Joseph, Dulcia Wei Ni Tan, Moreno Raja Miguel Ramon, et al.
ACS Nano|January 8, 2014
Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucomaJayaganesh V Natarajan, Anastasia Darwitan, Veluchamy A Barathi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 28, 2014
Sustained-release from nanocarriers: a reviewJayaganesh V Natarajan, Chandra Nugraha, Xu Wen Ng, et al.
Frontiers in Bioscience (Scholar Edition)|June 3, 2010
Polymer- and liposome-based nanoparticles in targeted drug deliverySubbu S Venkatraman, Lwin Lwin Ma, Jayaganesh V Natarajan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 23, 2003
Controlled targeting of liposomal doxorubicin via the folate receptor in vitroJustin M Saul, Ananth Annapragada, Jayaganesh V Natarajan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 4, 2005
Folate targeting of drug carriers: a mathematical modelKetan B Ghaghada, Justin Saul, Jayaganesh V Natarajan, et al.
International Journal of Nanomedicine|January 26, 2012
Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eyeJayaganesh V Natarajan, Marcus Ang, Anastasia Darwitan, et al.
Expert Opinion on Drug Delivery|May 13, 2016
Drug, delivery and devices for diabetic retinopathy (3Ds in DR)Jayabalan Nirmal, Krishna Radhakrishnan, Miguel Moreno, et al.
Drug Delivery and Translational Research|March 20, 2015
Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedropsTina T Wong, Gary D Novack, Jayaganesh V Natarajan, et al.
Plos One|September 21, 2011
Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eyeJayaganesh V Natarajan, Sujay Chattopadhyay, Marcus Ang, et al.
Scientific Reports|December 3, 2017
Characterization of liposomal carriers for the trans-scleral transport of RanibizumabRini Rachel Joseph, Dulcia Wei Ni Tan, Moreno Raja Miguel Ramon, et al.
ACS Nano|January 8, 2014
Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucomaJayaganesh V Natarajan, Anastasia Darwitan, Veluchamy A Barathi, et al.
Pageof 1